Woodline Partners’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.94M | Buy |
897,086
+225
| +0% | +$1.99K | 0.04% | 474 |
|
|
2025
Q1 | $7.02M | Buy |
896,861
+395,040
| +79% | +$3.09M | 0.05% | 426 |
|
|
2024
Q4 | $5.27M | Sell |
501,821
-1,185,492
| -70% | -$12.5M | 0.04% | 476 |
|
|
2024
Q3 | $22.1M | Buy |
1,687,313
+182,781
| +12% | +$2.4M | 0.19% | 178 |
|
|
2024
Q2 | $21.2M | Buy |
1,504,532
+4,008
| +0.3% | +$56.4K | 0.2% | 157 |
|
|
2024
Q1 | $25.3M | Sell |
1,500,524
-351,888
| -19% | -$5.94M | 0.23% | 139 |
|
|
2023
Q4 | $26.2M | Sell |
1,852,412
-50,431
| -3% | -$712K | 0.28% | 111 |
|
|
2023
Q3 | $19.6M | Buy |
1,902,843
+23,500
| +1% | +$242K | 0.23% | 134 |
|
|
2023
Q2 | $31M | Hold |
1,879,343
| – | – | 0.37% | 74 |
|
|
2023
Q1 | $17.2M | Buy |
1,879,343
+1,266,202
| +207% | +$11.6M | 0.23% | 121 |
|
|
2022
Q4 | $4.39M | Buy |
613,141
+516,235
| +533% | +$3.7M | 0.06% | 338 |
|
|
2022
Q3 | $485K | Sell |
96,906
-1,488,386
| -94% | -$7.45M | 0.01% | 594 |
|
|
2022
Q2 | $3.87M | Sell |
1,585,292
-530,737
| -25% | -$1.29M | 0.06% | 298 |
|
|
2022
Q1 | $14.5M | Sell |
2,116,029
-146,973
| -6% | -$1M | 0.23% | 128 |
|
|
2021
Q4 | $18.3M | Buy |
2,263,002
+535,942
| +31% | +$4.33M | 0.26% | 115 |
|
|
2021
Q3 | $16.9M | Buy |
1,727,060
+1,494,523
| +643% | +$14.6M | 0.28% | 101 |
|
|
2021
Q2 | $1.57M | Buy |
+232,537
| New | +$1.57M | 0.03% | 382 |
|